Charles River Laboratories Intl. Inc vs Kyndryl Holdings Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 4.6× Kyndryl Holdings Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals.
| CRL | KD | |
|---|---|---|
Market Cap | $13.46B | $2.91B |
Sector | Health | Technology |
52-Week High | $282.00 | $33.14 |
52-Week Low | $145.57 | $10.59 |
Enterprise Value | $16.30B | $5.74B |
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →